New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

SS-31 (Elamipretide)

From $60.00

Shop

SS-31 (Elamipretide) · Research brief

How to Mix SS-31 Calculator — Reconstitution Guide

52 WORDS

Short answer

Research from pharmaceutical development labs shows that up to 40% of reconstituted peptide samples fail stability testing not because of contamination. But because the dilution ratio was calculated incorrectly. SS-31 (Elamipretide), a mitochondria-targeting peptide with a molecular weight of 639.8 g/mol, demands precision in every step from lyophilised powder to injectable solution.

Key takeaways

  • SS-31 reconstitution requires molecular weight-specific water volumes calculated as Peptide Mass (mg) ÷ Target Concentration (mg/mL). Generic 1:1 ratios do not apply.
  • Bacteriostatic water must be injected slowly down the vial wall to prevent foaming and peptide denaturation at the air-water interface.
  • Dead space in syringes (0.05–0.1mL per draw) accumulates across protocols. Add 10% overfill to calculated volumes for studies requiring more than 10 injections.
  • Reconstituted SS-31 stored at 2–8°C in bacteriostatic water maintains stability for 28 days. Degradation accelerates beyond this window regardless of initial concentration accuracy.
  • Purpose-built mix SS-31 calculators reduce concentration error rates from 15–25% (manual) to under 2% by eliminating arithmetic mistakes and integrating overfill automatically.

Research from pharmaceutical development labs shows that up to 40% of reconstituted peptide samples fail stability testing not because of contamination. But because the dilution ratio was calculated incorrectly. SS-31 (Elamipretide), a mitochondria-targeting peptide with a molecular weight of 639.8 g/mol, demands precision in every step from lyophilised powder to injectable solution. One miscalculation during mixing renders the entire vial unusable for controlled research.

Our team has guided hundreds of researchers through peptide reconstitution protocols for compounds like Dihexa, P21, and SS-31. The gap between doing it right and wasting research-grade material comes down to three things most standard guides never mention: molecular weight-specific water volume, peptide stability windows post-reconstitution, and the hidden variable of injection dead space.

How do you mix SS-31 using a calculator to ensure accurate concentration?

To mix SS-31 calculator-verified reconstitution, divide the peptide mass in milligrams by your target concentration in mg/mL to determine exact bacteriostatic water volume. For a 5mg vial targeting 2mg/mL, add precisely 2.5mL sterile bacteriostatic water. The calculator eliminates manual arithmetic errors that compromise research integrity. This method applies universally to mitochondrial peptides including SS-31, ensuring consistent dosing across multi-week protocols.

Most researchers assume peptide mixing follows a generic 1:1 ratio. Add 1mL water to any vial and call it done. That assumption fails the moment you need reproducible dosing across a longitudinal study. SS-31's specific molecular structure and research applications require concentration precision within ±5% to maintain protocol validity. The calculator accounts for peptide mass variability between batches, dead space in syringes (typically 0.05–0.1mL per draw), and the stability curve of reconstituted SS-31 in bacteriostatic solution. This article covers the exact calculation formula, step-by-step reconstitution with contamination avoidance, comparison of manual vs calculator methods, scenario-based troubleshooting for common errors, and what actually happens when dilution ratios drift outside acceptable ranges.

Step 1: Calculate Bacteriostatic Water Volume Using SS-31 Peptide Mass

Every SS-31 vial lists peptide mass in milligrams on the label. Typically 5mg, 10mg, or 20mg depending on supplier and synthesis batch. To mix SS-31 calculator-verified concentrations, apply this formula: Bacteriostatic Water Volume (mL) = Peptide Mass (mg) ÷ Target Concentration (mg/mL). For a 5mg vial targeting 2mg/mL final concentration, you add exactly 2.5mL bacteriostatic water. For the same 5mg vial at 1mg/mL, you add 5mL water.

Target concentration depends on research protocol requirements. Mitochondrial function studies using SS-31 commonly target 1–2mg/mL to enable injection volumes between 0.1–0.5mL per dose without exceeding subcutaneous tissue tolerance. Higher concentrations (5mg/mL or above) reduce injection volume but increase peptide aggregation risk during storage. SS-31's tetrapeptide structure with aromatic residues makes it prone to self-association at concentrations above 3mg/mL in aqueous solution.

Dead space matters. Standard 1mL insulin syringes retain 0.05–0.08mL of solution in the hub and needle after injection. Multiply that by 20–30 injections across a study protocol and you've lost 1–2.4mL of reconstituted peptide. Researchers at Real Peptides working with compounds like Hexarelin account for this by adding 10% overfill to the calculated water volume. For a 2.5mL target, draw 2.75mL bacteriostatic water instead. The calculator can integrate overfill automatically if programmed with syringe type and expected draw count.

Step 2: Reconstitute SS-31 Using Aseptic Technique and Controlled Injection Rate

SS-31 arrives as lyophilised powder in a sealed sterile vial under vacuum or inert gas. Before adding any liquid, let the vial reach room temperature (20–25°C) for 10–15 minutes if stored refrigerated. Thermal shock from cold vial meeting room-temperature water can cause localized protein precipitation. Wipe the rubber stopper with 70% isopropyl alcohol and allow it to air-dry for 30 seconds. Residual alcohol mixing with bacteriostatic water dilutes the benzyl alcohol preservative below effective concentration (0.9% minimum).

Draw the calculated bacteriostatic water volume into a sterile syringe. Use a blunt-tip needle or standard 20–22 gauge needle to penetrate the stopper. Insert the needle at a 45-degree angle aimed at the vial wall, not the powder bed. Inject water slowly down the inside glass surface. The stream should contact the wall first and flow gently toward the powder. Injecting directly onto the lyophilised cake causes foaming and denatures peptide bonds at the air-water interface.

SS-31 typically dissolves within 60–90 seconds of gentle swirling. Do not shake. Shaking introduces air bubbles that denature surface-exposed peptide molecules and create measurement errors when drawing doses. If powder remains visible after two minutes, let the vial sit undisturbed for five minutes. Agitation increases temperature through friction and accelerates degradation. Once fully dissolved, the solution should be clear and colourless. Any cloudiness, visible particles, or colour shift indicates contamination or peptide aggregation. Discard the vial.

Step 3: Verify Final Concentration and Adjust for Measurement Error Using the Mix SS-31 Calculator

After reconstitution, verify the concentration matches your target by back-calculating from known peptide mass. If you added 2.5mL to a labeled 5mg vial, your theoretical concentration is 2mg/mL. But batch-to-batch peptide purity variance (typically 95–98% for research-grade synthesis) means actual concentration may range from 1.9–2.0mg/mL. High-precision studies require HPLC verification of final concentration, but for most mitochondrial research protocols, ±5% variance is acceptable.

Measurement error compounds across the protocol. If your syringe reads 2.5mL but actual delivered volume is 2.45mL due to meniscus reading error, your concentration shifts from 2.0mg/mL to 2.04mg/mL. A 2% increase that becomes meaningful across dose-response curves. Researchers working with dose-sensitive compounds like Tesofensine or SLU PP 332 use calibrated glass syringes or repeater pipettes to eliminate volumetric error.

The mix SS-31 calculator should output not just water volume but also per-dose volume for your protocol. If your study requires 1mg SS-31 per injection and you reconstituted to 2mg/mL, you draw 0.5mL per dose. Mark this on the vial label immediately after mixing. 14 days later when you're drawing dose 12, you won't remember the original calculation.

SS-31 Reconstitution Methods: Manual vs Calculator Comparison

Method Calculation Speed Error Rate Protocol Scalability Overfill Integration Professional Assessment
Manual arithmetic 2–5 minutes per vial 15–25% (arithmetic errors, unit conversion mistakes) Requires recalculation for each new vial size or target concentration Must be calculated separately and added manually Acceptable for single-vial pilot studies. Unacceptable for multi-vial longitudinal protocols where one error cascades across weeks
Spreadsheet calculator 30–60 seconds per vial 5–10% (data entry errors, formula mistakes in setup) Moderate. Formulas must be manually adjusted for different peptides or concentrations Can be programmed but requires formula editing Standard practice for academic labs. Reduces error compared to manual but lacks validation checks
Purpose-built mix SS-31 calculator 10–15 seconds per vial <2% (limited to input transcription errors only) High. Handles variable vial sizes, concentrations, and peptide types with pre-validated formulas Automatically integrated with user-defined syringe type Industry standard for GMP facilities and commercial research. Eliminates calculation as a variable, allows focus on aseptic technique and protocol execution

Manual calculation works until it doesn't. A researcher mixing five vials across a study might catch their own arithmetic error on vial two. But by vial four, fatigue increases mistake probability to 40% according to human factors research in pharmaceutical compounding. The calculator removes cognitive load entirely.

What If: SS-31 Mixing Scenarios

What If the Lyophilised Powder Doesn't Fully Dissolve After Adding Bacteriostatic Water?

Stop swirling and let the vial sit undisturbed at room temperature for 10–15 minutes. SS-31's tetrapeptide structure sometimes requires extended hydration time, especially if the powder was over-dried during lyophilisation. If powder remains after 15 minutes, do not add more water or increase agitation. Both introduce new variables that invalidate your concentration calculation. Gently warm the vial in your palm (not under hot water) to 30–32°C for two minutes while slowly rotating. Residual powder after this indicates either peptide aggregation during storage or manufacturing quality issues. The vial should be discarded and the supplier contacted.

What If You Accidentally Added More Bacteriostatic Water Than the Calculator Specified?

Do not attempt to remove excess water with a syringe. Introducing air into the vial increases oxidation risk and creates measurement uncertainty for all future doses. Instead, recalculate your actual concentration using the formula: Actual Concentration (mg/mL) = Peptide Mass (mg) ÷ Actual Water Volume Added (mL). If you added 3.0mL instead of 2.5mL to a 5mg vial, your concentration is 1.67mg/mL instead of 2.0mg/mL. Adjust your per-dose draw volume accordingly. For a 1mg dose, draw 0.6mL instead of 0.5mL. Label the vial with corrected concentration immediately to prevent future dosing errors.

What If the Reconstituted Solution Appears Cloudy or Contains Visible Particles?

Discard the vial immediately. Cloudiness indicates either peptide aggregation (caused by improper mixing technique, pH drift, or temperature shock) or bacterial contamination if non-sterile water was used. SS-31 in proper bacteriostatic solution at concentrations below 3mg/mL should be completely clear and colourless. Visible particles suggest protein precipitation or foreign matter introduced during reconstitution. Using the solution anyway compromises research validity and introduces uncontrolled variables. The cost of replacing one vial is negligible compared to invalidating weeks of data.

The Unforgiving Truth About SS-31 Reconstitution Calculators

Here's the honest answer: most researchers don't use a mix SS-31 calculator because they underestimate how often they make arithmetic errors. The assumption is that dividing 5 by 2 is simple enough not to require a tool. Until you're mixing vial number seven at the end of a 12-hour lab day and you write down 2.0mL when you meant 2.5mL. That one error doesn't just ruin that vial. It skews every data point from that vial across your entire protocol timeline.

The calculator isn't about intelligence or competence. It's about eliminating variability in a step that should never be variable. Pharmaceutical manufacturing facilities use automated calculators for every compounding step not because their technicians can't do math, but because human error rates in repetitive arithmetic tasks are measurably higher than automated calculation error rates. Research-grade peptide work deserves the same standard. If your protocol requires reproducible dosing within ±5%, manual calculation introduces a 15–25% error rate that destroys that requirement before the first injection.

The calculator also prevents the single most expensive peptide mistake: confusing milligrams with micrograms. SS-31 doses in mitochondrial research are typically measured in milligrams (1–5mg per injection for rodent models), but related peptides like KPV use microgram dosing. Mixing up mg/mL and μg/mL during manual calculation creates a 1000-fold concentration error. The kind of error that ends studies and wastes months of work.

Peptide reconstitution isn't where you demonstrate manual skill or mental math ability. It's where you eliminate every possible source of error so your actual research variables remain isolated and measurable. Use the calculator.

Once reconstituted, SS-31 stability becomes the limiting factor. Bacteriostatic water extends peptide viability to approximately 28 days when stored at 2–8°C, but degradation begins immediately upon mixing. The question is whether it remains within acceptable loss thresholds for your protocol duration. Studies on mitochondrial peptides including SS-31 show 8–12% potency loss over four weeks in bacteriostatic solution, accelerating to 25–40% loss if stored at room temperature. Freezing reconstituted SS-31 is not recommended. Ice crystal formation during freeze-thaw cycles disrupts peptide tertiary structure and causes irreversible aggregation.

The mix SS-31 calculator should account for storage duration when determining concentration. If your protocol runs six weeks and you're using a single vial, front-load concentration by 10–15% to compensate for degradation in the final week. For a target 2mg/mL effective concentration at week six, reconstitute to 2.2–2.3mg/mL initially. This prevents underdosing as the study progresses and maintains consistency across your entire dataset.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Divide the peptide mass in milligrams by your target concentration in mg/mL — this gives exact bacteriostatic water volume in milliliters. For a 5mg SS-31 vial targeting 2mg/mL, add precisely 2.5mL sterile bacteriostatic water. For the same vial at 1mg/mL, add 5.0mL. The formula is universal: Water Volume (mL) = Peptide Mass (mg) ÷ Target Concentration (mg/mL). Manual calculation introduces 15–25% error rates across multi-vial protocols — purpose-built calculators reduce this to under 2% by eliminating arithmetic mistakes.
Sterile water without preservative is acceptable only for immediate single-use reconstitution — the entire vial must be used within 24 hours because bacterial growth begins rapidly in preservative-free aqueous solutions stored at refrigeration temperatures. Bacteriostatic water contains 0.9% benzyl alcohol, which prevents microbial contamination for up to 28 days when stored at 2–8°C. For multi-dose protocols spanning weeks, bacteriostatic water is the only viable option. Using sterile water for a 14-day protocol risks bacterial contamination that invalidates research and introduces infection risk in animal models.
Excess water dilutes the peptide below your target concentration — recalculate actual concentration using the formula: Actual Concentration = Peptide Mass ÷ Actual Water Volume Added. If you added 3.0mL instead of 2.5mL to a 5mg vial, concentration drops from 2.0mg/mL to 1.67mg/mL. Adjust per-dose draw volumes accordingly to maintain consistent peptide delivery. Do not attempt to remove excess water with a syringe — this introduces air and increases oxidation risk. The diluted solution remains usable if you recalculate and relabel immediately.
Reconstituted SS-31 maintains acceptable stability for approximately 28 days when stored at 2–8°C in bacteriostatic water, though potency begins declining immediately upon mixing. Studies on mitochondrial peptides show 8–12% degradation over four weeks under refrigeration, accelerating to 25–40% loss at room temperature. Freezing is not recommended — ice crystal formation during freeze-thaw cycles causes irreversible peptide aggregation. For protocols longer than four weeks, use multiple smaller vials reconstituted sequentially rather than one large vial stored beyond 28 days.
Foaming occurs when bacteriostatic water is injected directly onto the lyophilised powder bed at high velocity — the turbulence creates air bubbles that denature peptide bonds at the air-water interface. Prevent foaming by injecting water slowly down the inside vial wall at a 45-degree angle, allowing it to flow gently toward the powder rather than hitting it directly. The stream should contact glass first, not powder. SS-31 typically dissolves within 60–90 seconds of gentle swirling without shaking. If foam forms, let the vial sit undisturbed for 10 minutes to allow bubbles to dissipate before use.
Yes — the formula (Peptide Mass ÷ Target Concentration = Water Volume) applies universally to all lyophilised peptides regardless of molecular weight or function. The calculator accounts for peptide-specific variables like molecular weight, recommended concentration ranges, and stability profiles. Mitochondrial peptides including SS-31, MOTS-c, and Humanin use identical reconstitution mathematics but differ in optimal storage concentrations — SS-31 aggregates above 3mg/mL while other peptides tolerate higher concentrations. The calculator should be programmed with peptide-specific parameters rather than using one-size-fits-all defaults.
Most rodent mitochondrial function protocols target 1–2mg/mL SS-31 concentration to enable subcutaneous injection volumes between 0.1–0.5mL per dose without exceeding tissue tolerance. Higher concentrations (3–5mg/mL) reduce injection volume but increase peptide aggregation risk during multi-week storage. Lower concentrations (0.5–1mg/mL) require larger injection volumes that may cause discomfort or tissue damage in small animals. The 1–2mg/mL range balances stability, injection volume, and dosing precision across typical 2–8 week protocols common in mitochondrial research.
Standard 1mL insulin syringes retain 0.05–0.08mL of solution in the hub and needle after each injection — multiply this by your total planned injections to calculate cumulative loss. For a 20-injection protocol, dead space wastes 1.0–1.6mL of reconstituted peptide. Compensate by adding 10% overfill to your calculated bacteriostatic water volume. For a 2.5mL target, draw 2.75mL instead. Purpose-built mix SS-31 calculators integrate overfill automatically when programmed with syringe type and expected draw count, preventing underdosing in later protocol stages.
Properly reconstituted SS-31 in bacteriostatic water at concentrations below 3mg/mL should be completely clear, colourless, and free of visible particles. Any cloudiness, colour shift (yellow, brown, or pink tint), or suspended particles indicates either peptide aggregation from improper mixing technique or bacterial contamination from non-sterile water or technique. Discard contaminated vials immediately — using compromised solution invalidates research data and introduces uncontrolled biological variables. Cloudiness developing during storage beyond 28 days is normal degradation signaling the solution has exceeded usable lifespan.
Lower concentrations (1–2mg/mL) provide better stability over extended storage periods because peptide aggregation risk decreases as intermolecular spacing increases in dilute solutions. SS-31’s aromatic amino acid residues promote self-association above 3mg/mL, accelerating degradation during multi-week refrigeration. For protocols exceeding three weeks, target 1.5mg/mL or below to minimize aggregation-driven potency loss. The tradeoff is larger per-dose injection volumes — but this is preferable to concentration-related stability failures that compromise data integrity across the study timeline.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now